Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd.,
TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to
TAIPEI, Taiwan, Dec. 3, 2021 /PRNewswire/ — Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin
Taipei, Taiwan, August 5, 2021 KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical
Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023 Bora has been awarded “Outstanding Company of